期刊文献+

RP-HPLC法测定雷尼酸锶中有关物质和含量 被引量:2

Determination of strontium ranelate and its related substances by RP-HPLC
下载PDF
导出
摘要 建立雷尼酸锶中有关物质检查与含量测定的RP-HPLC法,以Diamonsil C18柱(250mm×4.6mm,5μm);0.2%冰醋酸溶液(用三乙胺调节pH值至5.5)-甲醇(95∶5)为流动相,检测波长为234nm。在选定的色谱条件下,雷尼酸锶与有关物质及中间体分离完全,雷尼酸锶在0.005~0.250mg.mL-1范围内,峰面积与浓度线性关系良好(r=1),检测限为15ng,定量限为50ng。 RP-HPLC methods for the determination of strontium ranelate and its related substances were developed to control the quality of strontium ranelate.Chromatography was carried out on a Diamonsil C18 column(250mm×4.6mm,5μm),using a mobile phase of 0.2% acetic acid buffer(pH=5.5,adjusted by triethylamine):methanol(95∶5) with the ultraviolet detection wavelength at 234nm.Under the established chromatographic conditions,the related substances,intermediate and strontium ranelate can be separated completely.The established methods have been validated,and stability tests under various conditions have been performed.The standard curve is linear within the range of 0.005~0.250mg·mL-1 with the correlation coefficient of 1.The limits of detection and quantification were 15.0ng and 50.0ng,respectively.
出处 《海峡药学》 2011年第12期84-86,共3页 Strait Pharmaceutical Journal
关键词 HPLC 雷尼酸锶 有关物质 含量测定 HPLC Strontium ranelate Related substance Assay
  • 相关文献

参考文献3

二级参考文献23

  • 1蒋晔,丁翔宇,蒋懿,郝福,李艳荣.雷尼酸锶药效学与药动学的研究进展[J].中国医院药学杂志,2006,26(2):197-199. 被引量:6
  • 2王强,潘红娟,袁哲东.雷尼酸锶的合成[J].中国医药工业杂志,2007,38(2):76-77. 被引量:6
  • 3BOIVIN G, DELOFRE P, PERRAT B,et al. Strontium distribution and interactions with bone mineral in monkey iliac bone after strontiumsah( S12911 ) adminstration [ J ]. Bone Miner Res, 1996, 11(9): 1302-1311.
  • 4DE BROE ME,D'HAESE PC. Strontium and osteomalacia in renal failure patients [ J ]. Nephrol Dial Transplant, 2003,18 ( 1 ) : 215 -216.
  • 5DAHL SG,ALLAIN P,MARIE PJ,et al. Incorproation and distribution of strontium in bone[J]. Bone,2001,28(4) :446 -453.
  • 6BARBARA A, DELANNOY P, DENIS BG, et al. Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells[ J ]. Metabolism,2004,53 (4) :532 - 537.
  • 7TAKAHASHI N, SASAKI T. S12911-2 inhibits osteoclastie bone resorption in vitro [ J ]. Bone Miner Res, 2003,18 ( 6 ) : 1082 - 1087.
  • 8AMMANN P,SHEN V, ROBIN B,et al. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats [ J ]. Bone Miner Res, 2004, 19 ( 12 ) :2012 - 2020.
  • 9DELANNOY P, BAZOT D, MARIE PJ. Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice [ J ]. Metabolism,2002,51 ( 7 ) :906 - 911.
  • 10REGINSTER JY, DEROISY R, DOUGADOS M, et al. Prevention of early postmenopausal bone loss by strontium ranelate: a randomized, two-year, double-blind, dose-ranging, placebo-controlled trial[ J ]. Osteoporos lnt, 2002,13 ( 2 ) : 121 - 129.

共引文献8

同被引文献8

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部